GlaxoSmithKline CR`s Pre-Tax Profit Growth reached 66.5 % in 2017. This is 201 % less than in the previous year.
Buy Pre-Tax Profit Growth data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | % | ... | ... | ... | ... | ... | 55.9 | -37.5 | 9.53 | 30.0 | -12.4 | |||||||
| Bayer Czech Republic | % | ... | ... | ... | 27.9 | -47.7 | 20.5 | 10.1 | 19.8 | |||||||||
| GlaxoSmithKline Czech Republic | % | ... | ... | ... | 32.4 | -25.9 | -23.1 | -28.4 | 33.3 | |||||||||
| Merck Czech Republic | % | ... | ... | 208 | 20.3 | -41.4 | 9.51 | 89.2 | ||||||||||
| Novartis Czech Republic | % | -1.98 | -2.34 | 4.60 | 70.8 | 17.6 | ||||||||||||
| Pfizer Czech Republic | % | ... | ... | 132 | -79.1 | 198 | -6.94 | -44.5 | ||||||||||
| Roche Czech Republic | % | ... | ... | ... | -39.1 | -14.2 | 157 | -26.8 | -39.4 | ... | ||||||||
| Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 51.8 | -18.2 | 50.6 | -98.0 | 5,393 | ||||||||
| Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 6.02 | 1.33 | 12.5 | ||
| Walmark | % | ... | ... | ... | 44.2 | -91.9 | -108 | -4,319 | -1,273 |
Helgi Library 
